BN 52111
| Code | Size | Price |
|---|
| TAR-T26876-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T26876-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T26876-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
BN 52111 is a platelet activating factor antagonist.
CAS:
120889-14-7
Formula:
C33H58BrNO4
Molecular Weight:
612.734
Purity:
0.98
SMILES:
[Br-].CCCCCCCCCCCCCCCCCC1(C)OCC(COC(=O)CCCCC[n+]2ccccc2)O1
References
1. Braquet P, Hosford D, Koltz P, Guilbaud J, Paubert-Braquet M. Effect of platelet-activating factor on tumor necrosis factor-induced superoxide generation from human neutrophils. Possible involvement of G proteins. Lipids. 1991 Dec;26(12):1071-5. PubMed PMID: 1668107.
2. Paubert-Braquet M, Hosford D, Klotz P, Guilbaud J, Braquet P. Tumor necrosis factor alpha 'primes' the platelet-activating factor-induced superoxide production by human neutrophils: possible involvement of G proteins. J Lipid Mediat. 1990;2 Suppl:S1-4. PubMed PMID: 1966810.
3. Pons F, Touvay C, Lejeune V, Carr? C, Vilain B, Broquet C, Mencia-Huerta JM, Braquet P. Action of platelet-activating factor (PAF) antagonists on the bronchopulmonary effects of PAF in the guinea-pig. J Lipid Mediat. 1989 Nov-Dec;1(6):329-40. PubMed PMID: 2519901.
4. Mandi Y, Farkas G, Koltai M, Beladi I, Mencia-Huerta JM, Braquet P. The effect of the platelet-activating factor antagonist, BN 52021, on human natural killer cell-mediated cytotoxicity. Immunology. 1989 Jul;67(3):370-4. PubMed PMID: 2759659; PubMed Central PMCID: PMC1385355.